The above chart presents the market trend analysis for harbin hejia pharmaceutical co.ltd. from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 35 transactions, with a transaction quantity of 17260 and a transaction weight of 0.
Product description
Nguyên liệu sản xuất thuốc thú y - CEFOTAXIME SODIUM Kháng sinh. Nhà sx:Harbin Hejia Pharmaceutical Co., LTD. số lô: SC202505003, ngày sx 10.05.2025, hsd 09.05.2027. Hàng mới 100%
Expand
Product description
PHARMACEUTICAL ALLOPATHIC RAW MATERIAL ITEM NAME CEFOTAXIME SODIUM STERLIE USP BATCH NO. SN202601007 MFG DATE 06-01-26 / EXPIRY DATE 05-01-29 NET WEIGHT 100 KGS QTY 10 CTNS BRAND HERBIN I/O AND SHIPMENT FROM CHINA DRAP NOC PIC-D/R/002409/32026 DATED 26-03-26
Expand
+View All
Partners
Total 67
RankCompanyTransactionsPerDetail
1зао синтез
russiabuyer,they trade on 2021-05-26
268.55%
>
harbin hejia pharmaceutical co.ltd. is china Buyer&Supplier,
and primarily engages in the import and export business of products such as cefotaxime sodium sterile,pharmaceutical raw material,bat.
According to the 52wmb.com global trade database, as of 2026-06-18, the company has completed 304 international trades,
with its main trading regions covering pakistan,russia,vietnam etc.
The core products include HS29419090,HS29419000,HS30049099 etc,
often transported via qingdao etc,
and its main trading partners are зао синтез,indus pharma private,daneen pharma pvt ltd..
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on harbin hejia pharmaceutical co.ltd. is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.